{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T03:41:53Z","timestamp":1784346113702,"version":"3.55.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T00:00:00Z","timestamp":1515542400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","valueinhealthjournal.com","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.jval.2017.07.014","type":"journal-article","created":{"date-parts":[[2018,2,4]],"date-time":"2018-02-04T20:35:47Z","timestamp":1517776547000},"page":"407-415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Cost-Effectiveness of Take-Home Naloxone for the Prevention of Overdose Fatalities among Heroin Users in the United Kingdom"],"prefix":"10.1016","volume":"21","author":[{"given":"Sue","family":"Langham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antony","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Kenworthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Grieve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.N.","family":"Dunlop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jval.2017.07.014_bib1","series-title":"European Drug Report 2015: Trends and Developments","year":"2015"},{"key":"10.1016\/j.jval.2017.07.014_bib2","series-title":"Drug-Related Deaths Summit","year":"2015"},{"key":"10.1016\/j.jval.2017.07.014_bib3","series-title":"Preventing Fatal Overdoses: A Systematic Review of the Effectiveness of Take-Home Naloxone","year":"2015"},{"key":"10.1016\/j.jval.2017.07.014_bib4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/ADM.0000000000000034","article-title":"A systematic review of community opioid overdose prevention and naloxone distribution programs","volume":"8","author":"Clark","year":"2014","journal-title":"J Addict Med"},{"key":"10.1016\/j.jval.2017.07.014_bib5","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/add.13265","article-title":"Effectiveness of Scotland\u2019s national naloxone programme for reducing opioid-related deaths: a before (2006\u201310) versus after (2011\u201313) comparison","volume":"111","author":"Bird","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.jval.2017.07.014_bib6","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/add.13326","article-title":"Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria","volume":"111","author":"McDonald","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.jval.2017.07.014_bib7","series-title":"Preventing Opioid Overdose Deaths with Take-Home Naloxone","year":"2016"},{"key":"10.1016\/j.jval.2017.07.014_bib8","year":"2014","journal-title":"Community management of opioid overdose."},{"key":"10.1016\/j.jval.2017.07.014_bib9","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1136\/bmj.322.7291.895","article-title":"Take home naloxone and the prevention of deaths from opiate overdose: two pilot schemes","volume":"322","author":"Dettmer","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.jval.2017.07.014_bib10","author":"Clausen","year":"2014","journal-title":"Naloxone nasal spray in Norway"},{"key":"10.1016\/j.jval.2017.07.014_bib11","author":"Saelan","year":"2014","journal-title":"The Danish naloxone scheme."},{"key":"10.1016\/j.jval.2017.07.014_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-158-1-201301010-00003","article-title":"Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal","volume":"158","author":"Coffin","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jval.2017.07.014_bib13","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1016\/S2468-2667(17)30006-3","article-title":"Effects of naloxone distribution alone or in combination with addiction treatment with or without pre-exposure prophylaxis for HIV prevention in people who inject drugs: a cost-effectiveness modelling study","volume":"2","author":"Uyei","year":"2017","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.jval.2017.07.014_bib14","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3111\/13696998.2013.811080","article-title":"Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal in Russian cities","volume":"16","author":"Coffin","year":"2013","journal-title":"J Med Econ"},{"key":"10.1016\/j.jval.2017.07.014_bib15","year":"2015","journal-title":"Deaths related to drug poisoning in England and Wales: 2014 registrations."},{"key":"10.1016\/j.jval.2017.07.014_bib16","article-title":"The Secretary of State and the Minister for Health, Social Services and Public Safety. The Human Medicines (Amendment) (No. 3) Regulations 2015","year":"2015","journal-title":"Norwich, UK: Queen\u2019s Printer of Acts of Parliament,"},{"key":"10.1016\/j.jval.2017.07.014_bib17","series-title":"Take-Home Naloxone for Opioid Overdose in People Who Use Drugs","year":"2015"},{"key":"10.1016\/j.jval.2017.07.014_bib18","series-title":"A Language and Environment for Statistical Computing","year":"2016"},{"key":"10.1016\/j.jval.2017.07.014_bib19","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/0272989X9301300409","article-title":"Markov models in medical decision making: a practical guide","volume":"13","author":"Sonnenberg","year":"1993","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jval.2017.07.014_bib20","year":"2015","journal-title":"National life tables, United Kingdom: 2012\u20132014."},{"key":"10.1016\/j.jval.2017.07.014_bib21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jsat.2012.11.002","article-title":"Trends of heroin use and heroin injection epidemics in Europe: findings from the EMCDDA treatment demand indicator (TDI)","volume":"45","author":"Barrio","year":"2013","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.jval.2017.07.014_bib22","year":"2015","journal-title":"National life tables, United Kingdom, 1980\u201382 to 2012\u201314."},{"key":"10.1016\/j.jval.2017.07.014_bib23","first-page":"66","article-title":"Take-home naloxone to prevent fatalities from opiate-overdose: protocol for Scotland\u2019s public health policy evaluation, and a new measure to assess impact","volume":"22","author":"Bird","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.jval.2017.07.014_bib24","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1360-0443.1999.9421993.x","article-title":"Preventing opiate overdose fatalities with take-home naloxone: pre-launch study of possible impact and acceptability","volume":"94","author":"Strang","year":"1999","journal-title":"Addiction"},{"key":"10.1016\/j.jval.2017.07.014_bib25","series-title":"National Naloxone Programme Scotland\u2014Monitoring Report 2014\/15","year":"2015"},{"key":"10.1016\/j.jval.2017.07.014_bib26","year":"2014","journal-title":"Take home naloxone 2013\u201314."},{"key":"10.1016\/j.jval.2017.07.014_bib27","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1111\/j.1360-0443.2008.02314.x","article-title":"Overdose training and take-home naloxone for opiate users: prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses","volume":"103","author":"Strang","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.jval.2017.07.014_bib28","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s11524-013-9803-1","article-title":"Take-home emergency naloxone to prevent heroin overdose deaths after prison release: rationale and practicalities for the N-ALIVE randomized trial","volume":"90","author":"Strang","year":"2013","journal-title":"J Urban Health"},{"key":"10.1016\/j.jval.2017.07.014_bib29","first-page":"320","article-title":"The impact of take-home naloxone distribution and training on opiate overdose knowledge and response: an evaluation of the THN Project in Wales","volume":"19","author":"Bennett","year":"2012","journal-title":"Drugs (Abingdon Engl)"},{"key":"10.1016\/j.jval.2017.07.014_bib30","series-title":"UK Ambulance Services Clinical Practice Guidelines","year":"2016"},{"key":"10.1016\/j.jval.2017.07.014_bib31","series-title":"Evaluation of the Take Home Naloxone Demonstration Project","author":"Bennett","year":"2011"},{"key":"10.1016\/j.jval.2017.07.014_bib32","series-title":"British National Formulary (BNF) 67","year":"2016"},{"key":"10.1016\/j.jval.2017.07.014_bib33","series-title":"The NTA Overdose and Naloxone Training Programme for Families and Carers","year":"2011"},{"key":"10.1016\/j.jval.2017.07.014_bib34","series-title":"Unit Costs of Health and Social Care 2015","author":"Curtis","year":"2015"},{"key":"10.1016\/j.jval.2017.07.014_bib35","year":"2015","journal-title":"NHS reference costs 2014 to 2015."},{"key":"10.1016\/j.jval.2017.07.014_bib36","year":"2013","journal-title":"Guide to the methods of technology appraisal"},{"key":"10.1016\/j.jval.2017.07.014_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta11090","article-title":"Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation","volume":"11","author":"Connock","year":"2007","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jval.2017.07.014_bib38","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.drugalcdep.2016.02.042","article-title":"Naloxone without the needle\u2014systematic review of candidate routes for non-injectable naloxone for opioid overdose reversal","volume":"163","author":"Strang","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jval.2017.07.014_bib39","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.2146\/ajhp130798","article-title":"Intranasal naloxone administration for treatment of opioid overdose","volume":"71","author":"Robinson","year":"2014","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jval.2017.07.014_bib40","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1360-0443.2007.02097.x","article-title":"Intranasal naloxone for the treatment of suspected heroin overdose","volume":"103","author":"Kerr","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.jval.2017.07.014_bib41","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13722-016-0068-3","article-title":"Opioid overdose prevention and naloxone rescue kits: what we know and what we don\u2019t know","volume":"12","author":"Kerensky","year":"2017","journal-title":"Addict Sci Clin Pract"},{"key":"10.1016\/j.jval.2017.07.014_bib42","doi-asserted-by":"crossref","first-page":"788","DOI":"10.2105\/AJPH.2008.146647","article-title":"Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose","volume":"99","author":"Doe-Simkins","year":"2009","journal-title":"Am J Public Health"},{"key":"10.1016\/j.jval.2017.07.014_bib43","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","article-title":"Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews","volume":"378","author":"Nelson","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jval.2017.07.014_bib44","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.drugalcdep.2016.02.031","article-title":"Engagement in a national naloxone programme among people who inject drugs","volume":"162","author":"McAuley","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jval.2017.07.014_bib45","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s11524-008-9273-z","article-title":"Attitudes of Australian heroin users to peer distribution of naloxone for heroin overdose: perspectives on intranasal administration","volume":"85","author":"Kerr","year":"2008","journal-title":"J Urban Health"},{"key":"10.1016\/j.jval.2017.07.014_bib46","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s40273-016-0479-8","article-title":"Benefits, challenges and potential strategies of open source health economic models","volume":"35","author":"Dunlop","year":"2017","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jval.2017.07.014_bib47","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1360-0443.2012.04066.x","article-title":"A record-linkage study of drug-related death and suicide after hospital discharge among drug-treatment clients in Scotland, 1996\u20132006","volume":"108","author":"Merrall","year":"2013","journal-title":"Addiction"},{"key":"10.1016\/j.jval.2017.07.014_bib48","doi-asserted-by":"crossref","first-page":"e0141073","DOI":"10.1371\/journal.pone.0141073","article-title":"Drugs-related death soon after hospital-discharge among drug treatment clients in Scotland: record linkage, validation, and investigation of risk-factors","volume":"10","author":"White","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jval.2017.07.014_bib49","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jurban\/jtg029","article-title":"Fatal heroin-related overdose in San Francisco, 1997\u20132000: a case for targeted intervention","volume":"80","author":"Davidson","year":"2003","journal-title":"J Urban Health"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301518300019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301518300019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T09:58:36Z","timestamp":1535104716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301518300019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S1098301518300019"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2017.07.014","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-Effectiveness of Take-Home Naloxone for the Prevention of Overdose Fatalities among Heroin Users in the United Kingdom","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2017.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}